{"organizations": [], "uuid": "347e17ce70f39d13ef2c0b3bdacc94a0158a6069", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180108.html", "section_title": "Archive News &amp; Video for Monday, 08 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-uniqure-says-as-of-dec-31-co-had-1/brief-uniqure-says-as-of-dec-31-co-had-159-mln-in-cash-cash-equivalents-idUSASB0C01R", "country": "US", "domain_rank": 408, "title": "BRIEF-Uniqure Says As Of Dec 31 Co Had $159 Mln In Cash & Cash Equivalents", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.02, "site_type": "news", "published": "2018-01-08T20:13:00.000+02:00", "replies_count": 0, "uuid": "347e17ce70f39d13ef2c0b3bdacc94a0158a6069"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-uniqure-says-as-of-dec-31-co-had-1/brief-uniqure-says-as-of-dec-31-co-had-159-mln-in-cash-cash-equivalents-idUSASB0C01R", "ord_in_thread": 0, "title": "BRIEF-Uniqure Says As Of Dec 31 Co Had $159 Mln In Cash & Cash Equivalents", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "mln in cash & cash equivalents jan", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}, {"name": "uniqure nv", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 8 (Reuters) - Uniqure Nv:\n* UNIQURE PROVIDES YEAR-END 2017 CORPORATE UPDATE AND OUTLINES NEAR-TERM OBJECTIVES TO FURTHER DRIVE SHAREHOLDER VALUE\n* UNIQURE - AS OF DEC 31, 2017, CO HAD ABOUT $159 MILLION IN CASH & CASH EQUIVALENTS; EXPECTS CASH ON HAND SUFFICIENT TO FUND OPERATIONS INTO 2020\n* UNIQURE NV - INTENDS TO INITIATE GLOBAL, PIVOTAL PROGRAM FOR AMT-061 IN HEMOPHILIA B DURING Q3 2018\n* UNIQURE NV - AMENDMENT TO EXISTING INVESTIGATIONAL NEW DRUG (IND) APPLICATION EXPECTED FOR AMT-061 TO BE SUBMITTED TO FDA IN Q1 2018 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-08T20:13:00.000+02:00", "crawled": "2018-01-09T17:17:06.008+02:00", "highlightTitle": ""}